(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 4. The role of p38 MAPK during neutrophil chemotaxis to fMLP. (a) Human neutrophils treated with the p38 MAPK inhibitor SB20580 did not chemotax to fMLP in a long-term chemotactic assay. (b) Murine neutrophils treated with the p38 MAPK inhibitor SB203580, or deficient in MK2, did not chemotax to fMLP in a long-term chemotactic assay. (c) Murine neutrophils treated with the p38 MAPK inhibitor SB203580, or deficient in MK2, did not polarize in response to fMLP. n=4 for all data; *P<0.05, ANOVA with Bonferroni's correction.